1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. The Journal of the American Medical Association. 2007; 298(17): 2038-47.
2. Kheder-Elfekih R, Yannoutsos A, Blacher J, London GM, Safar ME. Hypertension and chronic kidney disease: respective contribution of mean and pulse pressure and arterial stiffness. Journal of Hypertension. 2015; 33(10): 2010-15.
3. Liamis G, Rodenburg EM, Hofman A, Zietse R, Stricker BH, Hoorn EJ. Electrolyte disorders in community subjects: Prevalence and risk factors. The American Journal of Medicine. 2013; 126(3): 256-63.
4. Lim LM, Tsai NC, Lin MY, Hwang DY, Lin HY, Lee JJ, et al. Hyponatremia is associated with fluid imbalance and adverse renal outcome in chronic kidney disease patients treated with diuretics. Scientific Reports. 2016; 6: 1-10.
5. Hooi LS, Ong LM, Ahmad G, Bavanandan S, Ahmad NA, Naidu BM, et al. A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia. Kidney International. 2013; 84(5): 1034-40.
6. MacIsaac RJ, Ekinci EI, Premaratne E, Lu ZX, Seah JM, Li Y, et al. The chronic kidney disease-epidemiology collaboration (CKD-EPI) equation does not improve the underestimation of glomerular filtration rate (GFR) in people with diabetes and preserved renal function. BMC Nephrology. 2015; 16: 1-13.
7. Yusoff SN, Zulkifli Z. Rethinking of old age: the emerging challenge for Malaysia. International Proceedings of Economics Development and Research. 2014; 71(13): 69-73.
8. Malabu UH, Porter D, Vangaveti VN, Kazi M, Kennedy RL. Prevalence of hyponatremia in acute medical admissions in tropical Asia Pacific Australia. Asian Pacific Journal of Tropical Medicine. 2014: 7(1): 40-3.
9. Bash LD, Coresh J, Köttgen A, Parekh RS, Fulop T, Wang Y, et al. Defining incident chronic kidney disease in the research setting: the ARIC study. American Journal of Epidemiology. 2009; 170(4): 414-24.
10. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. The Journal of the American Medical Association. 2012; 307(18): 1941-51.
11. Fastbom J, Wills P, Cornelius C, Viitanen M, Winblad B. Levels of serum creatinine clearance over the age of 75: a study of an elderly Swedish population. Archives of Gerontology and Geriatrics. 1996; 23(2): 179-88.
12. Kummer S, Gersdorff VG, Kemper MJ, Oh J. The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease. Pediatric Nephrology. 2012; 27(8): 1213-9.
13. Keane WF, Brenner BM, De Zeeuw D, Grunfeld JP, McGill J, Mitch WE, et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney International. 2003; 63(4): 1499-507.
14. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. American Journal of Kidney Diseases.2004; 43(5 suppl 1): S1-S290.
15. Loyd J, Wright P. Are thiazide diuretics an effective treatment for hypertension in patients with chronic kidney disease?. The Journal of Oklahoma State Medical Association. 2008; 101(5): 84-85.
16. Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH. Chronic kidney disease, fluid overload and diuretics: a complicated triangle. PLoS ONE. 2016; 11(7): 1-13.
17. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third national health and nutrition examination survey (1988–1994). Archives of Internal Medicine. 2001: 161(9): 1207-16.
18. Nigwekar SU, Waikar SS. Diuretics in acute kidney injury. Seminars in Nephrology. 2011; 31(6): 523-34.
19. Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload in acute heart failure-Re-distribution and other mechanisms beyond fluid accumulation. European Journal of Heart Failure. 2008: 10(2): 165–9.
20. McKie PM, Schirger JA, Benike SL, Harstad LK, Chen HH. The effects of dose reduction of furosemide on glomerular filtration rate in stable systolic heart failure. A Journal of the American College of Cardiology: Heart failure. 2014; 2(6): 675-7.
21. Vander AJ, Carlson J. Mechanism of the effects of furosemide on renin secretion in anesthetized dogs. Circulation Research. 1969; 25: 145-52.
22. American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American heart association nutrition committee. Circulation. 2006; 114(1): 82-96.
23. Adler AI, Stratton IM, Neil HAW, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. The British Medical Journal. 2000; 321(7258): 412-9.
24. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003; 107(22): 2864-9.